Skip to content
Use caution Drug recall · FDA · Published July 28, 2015

Sandoz Dexmethylphenidate 10mg Recall: Dissolution Failure

Sandoz recalls 10,767 bottles of Dexmethylphenidate HCl Extended-Release Capsules due to failed dissolution specifications. Check your lot number.

🇺🇸 FDA recall #D-1430-2015DrugSandoz ›
Take action

Contact the company

Recalling firmNovartis Pharmaceuticals Corp.25 Old Mill Rd · Suffern, NY 10901-4106
✎ GovInfoNow plain-language explainer

What happened, in plain English

Sandoz Inc. is recalling one lot of Dexmethylphenidate HCl Extended-Release Capsules, 10mg, because the drug did not dissolve properly during stability testing. This means the medication may not release its active ingredient at the intended rate, potentially affecting how well it works for patients. The recall involves 10,767 bottles distributed from New Jersey. Read more at govinfonow.com/recall/43885-novartis-pharmaceuticals-corp-recalls-dexmethylphenidate-hcl-extended-release-capsules-10mg.

Source Summary by GovInfoNow · govinfonow.com/recall/43885-novartis-pharmaceuticals-corp-recalls-dexmethylphenidate-hcl-extended-release-capsules-10mg · Updated October 12, 2026 · FDA enforcement record: FDA #D-1430-2015

Cite this page

“Sandoz Dexmethylphenidate 10mg Recall: Dissolution Failure.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/43885-novartis-pharmaceuticals-corp-recalls-dexmethylphenidate-hcl-extended-release-capsules-10mg. Based on FDA recall #D-1430-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1430-2015%22&limit=1).

Why it’s dangerous

The product failed dissolution specifications at the 6-hour time point during testing. This defect means the extended-release mechanism may not function as designed, leading to unpredictable drug absorption and potentially reduced therapeutic effect for conditions like ADHD.

Who’s affected

Patients currently taking Dexmethylphenidate HCl Extended-Release Capsules, 10mg, who purchased the specific recalled lot. Individuals with this prescription should check their bottle against the recall details.

How to tell if you have this one

Look for Dexmethylphenidate HCl Extended-Release Capsules, 10mg, Rx only, in bottles of 100. The specific recalled lot number is F0002 with an expiration date of 12/2016. Manufactured by Alkermes Gainesville LLC for Sandoz Inc.

  • Brand
    Sandoz
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check your medication bottle

    Verify if your Dexmethylphenidate HCl Capsules match the recalled lot number F0002 and expiration date 12/2016.

  2. Contact your pharmacist or doctor

    If you have the recalled product, speak with your healthcare provider about alternative treatment options since no specific remedy is listed in the record.

Where it went and when

Where it was distributed

Distributed in New Jersey.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: yesNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “NJ - site for distributor” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: New Jersey.

Recall timeline

FDA terminated this recall 21 months after the firm started it.

1. Firm started the recall: Jul 28, 201512. FDA classified it Class III: Sep 14, 201523. Published in FDA’s Enforcement Report: Sep 23, 201534. FDA terminated the recall: May 10, 2017420152017
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Sandoz recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1430-2015 (July 28, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1430-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA